GLP-1 Receptor Agonist and SGLT2 inhibitor use and Transcatheter Aortic Valve Replacement Outcomes: A Critique and Partial Re-Analysis. Wang J. Am J Cardiol 2026 Mar 8:S0002-9149(26)00152.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang J. GLP-1 Receptor Agonist and SGLT2 inhibitor use and Transcatheter Aortic Valve Replacement Outcomes: A Critique and Partial Re-Analysis. Am J Cardiol 2026 Mar 8:S0002-9149(26)00152.
PMID: 41806961